IDEXX Laboratories, Inc. (LON: 0J8P)
London
· Delayed Price · Currency is GBP · Price in USD409.23
-8.06 (-1.93%)
Dec 23, 2024, 5:41 PM BST
IDEXX Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Revenue | 3,845 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | Upgrade
|
| Revenue Growth (YoY) | 7.16% | 8.72% | 4.73% | 18.79% | 12.45% | 8.75% | Upgrade
|
| Cost of Revenue | 1,510 | 1,471 | 1,363 | 1,326 | 1,136 | 1,041 | Upgrade
|
| Gross Profit | 2,334 | 2,190 | 2,004 | 1,889 | 1,571 | 1,366 | Upgrade
|
| Selling, General & Admin | 947.11 | 901.89 | 850.75 | 796.4 | 735.27 | 668.61 | Upgrade
|
| Research & Development | 213.88 | 190.95 | 254.82 | 161.01 | 141.25 | 133.19 | Upgrade
|
| Operating Expenses | 1,161 | 1,093 | 1,106 | 957.4 | 876.52 | 801.8 | Upgrade
|
| Operating Income | 1,173 | 1,097 | 898.77 | 932.03 | 694.52 | 563.75 | Upgrade
|
| Interest Expense | -32.97 | -41.58 | -39.86 | -29.81 | -33.13 | -31.06 | Upgrade
|
| Interest & Investment Income | 14.13 | 5.63 | 1.07 | 0.43 | 0.59 | 0.43 | Upgrade
|
| EBT Excluding Unusual Items | 1,155 | 1,061 | 859.97 | 902.65 | 661.99 | 533.12 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -10.9 | Upgrade
|
| Pretax Income | 1,093 | 1,061 | 859.97 | 902.65 | 661.99 | 522.22 | Upgrade
|
| Income Tax Expense | 226.87 | 216.13 | 180.88 | 157.81 | 79.85 | 94.43 | Upgrade
|
| Earnings From Continuing Operations | 866.24 | 845.04 | 679.09 | 744.84 | 582.13 | 427.79 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0 | -0.36 | -0.07 | Upgrade
|
| Net Income | 866.24 | 845.04 | 679.09 | 744.85 | 581.78 | 427.72 | Upgrade
|
| Net Income to Common | 866.24 | 845.04 | 679.09 | 744.85 | 581.78 | 427.72 | Upgrade
|
| Net Income Growth | 5.29% | 24.44% | -8.83% | 28.03% | 36.02% | 13.44% | Upgrade
|
| Shares Outstanding (Basic) | 83 | 83 | 84 | 85 | 85 | 86 | Upgrade
|
| Shares Outstanding (Diluted) | 84 | 84 | 85 | 87 | 87 | 88 | Upgrade
|
| Shares Change (YoY) | -0.42% | -0.74% | -2.28% | -0.17% | -0.94% | -1.05% | Upgrade
|
| EPS (Basic) | 10.46 | 10.17 | 8.12 | 8.74 | 6.82 | 4.97 | Upgrade
|
| EPS (Diluted) | 10.36 | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 | Upgrade
|
| EPS Growth | 5.57% | 25.28% | -6.63% | 28.17% | 37.22% | 14.79% | Upgrade
|
| Free Cash Flow | 792.6 | 772.88 | 394.15 | 636 | 541.11 | 304.19 | Upgrade
|
| Free Cash Flow Per Share | 9.48 | 9.20 | 4.66 | 7.35 | 6.24 | 3.47 | Upgrade
|
| Gross Margin | 60.72% | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | Upgrade
|
| Operating Margin | 30.52% | 29.97% | 26.69% | 28.99% | 25.66% | 23.42% | Upgrade
|
| Profit Margin | 22.53% | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | Upgrade
|
| Free Cash Flow Margin | 20.61% | 21.11% | 11.71% | 19.78% | 19.99% | 12.64% | Upgrade
|
| EBITDA | 1,299 | 1,212 | 1,011 | 1,037 | 790.52 | 651.76 | Upgrade
|
| EBITDA Margin | 33.80% | 33.11% | 30.01% | 32.24% | 29.21% | 27.08% | Upgrade
|
| D&A For EBITDA | 125.97 | 114.91 | 111.9 | 104.6 | 96 | 88.01 | Upgrade
|
| EBIT | 1,173 | 1,097 | 898.77 | 932.03 | 694.52 | 563.75 | Upgrade
|
| EBIT Margin | 30.52% | 29.97% | 26.69% | 28.99% | 25.66% | 23.42% | Upgrade
|
| Effective Tax Rate | 20.75% | 20.37% | 21.03% | 17.48% | 12.06% | 18.08% | Upgrade
|
| Revenue as Reported | 3,845 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | Upgrade
|
| Advertising Expenses | - | 4.2 | 5 | 3.3 | 1.4 | 1.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.